BMJ Open Gastroenterology · 2026-07-02
Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications
Phrase rank #1 · DOI 10.1136/bmjgast-2026-002294
Other observed topics
MASLD
Observed in 82 articles across 17 journals.
Latest share0.09%
Change vs baseline-0.28 pp
Months observed12
Latest monthJul 2026
Portfolio article share
Attention over this snapshot
13 monthly points
Journal breadth
Where it appears
- Gut47
- Frontline Gastroenterology8
- BMJ Open Diabetes Research & Care5
- eGastroenterology4
- BMJ Open3
- BMJ Open Gastroenterology3
- Journal of Clinical Pathology2
- BMJ Evidence-Based Medicine1
- BMJ Medicine1
- BMJ Nutrition, Prevention & Health1
- BMJ Open Respiratory Research1
- BMJ Open Sport & Exercise Medicine1
Co-occurrence
Explore nearby topics
Inspect the source signal
Article evidence
30 high-ranking examples
Frontline Gastroenterology · 2026-04-22
Ageing liver in the era of MASLD: risks, mechanisms and treatment opportunities
Phrase rank #1 · DOI 10.1136/flgastro-2026-103677
Journal of Clinical Pathology · 2025-10-29
AI portal tract detection and characterisation for a regional analysis of steatosis and inflammation in MASLD, MASH and AIH
Phrase rank #1 · DOI 10.1136/jcp-2025-210311
Gut · 2025-10-06
P19 Understanding awareness and screening practices for MASLD amongst non-gastroenterology clinicians – a national survey study
Phrase rank #1 · DOI 10.1136/gutjnl-2025-BASL.35
eGastroenterology · 2025-08-24
Gut dysbiosis is linked to severe steatosis and enhances its diagnostic performance in MASLD
Phrase rank #1 · DOI 10.1136/egastro-2025-100204
Gut · 2026-06-26
IDDF2026-ABS-0291 Flavonoid supplementation improves liver injury markers and insulin resistance in MASLD: a systematic review and meta-analysis of randomized controlled trials
Phrase rank #2 · DOI 10.1136/gutjnl-2026-IDDF.198
Gut · 2026-06-26
IDDF2026-ABS-0012 Prediabetes as an early warning signal for advanced fibrosis in non-diabetic MASLD patients: a non-invasive risk stratification study
Phrase rank #2 · DOI 10.1136/gutjnl-2026-IDDF.168
Gut · 2026-06-23
O14 Improvement in health-related quality of life in non-cirrhotic and cirrhotic patients with MASLD treated with resmetirom: data from MAESTRO-NAFLD
Phrase rank #2 · DOI 10.1136/gutjnl-2026-BSG.14
Gut · 2026-06-23
FP30 Universal FIB4 screening, automated secondary care referral, new cirrhosis diagnosis - intelligent MASLD detection within the iDiabetesPlus precision care platform
Phrase rank #2 · DOI 10.1136/gutjnl-2026-BSG.107
BMJ Open Diabetes Research & Care · 2026-06-03
Reduced circulating Mig-6 levels are associated with dysglycemia in metabolic dysfunction associated steatotic liver disease (MASLD)
Phrase rank #2 · DOI 10.1136/bmjdrc-2026-005947
Gut · 2026-03-18
Targeting lipid droplets in the management of MASLD
Phrase rank #2 · DOI 10.1136/gutjnl-2026-338145
Gut · 2025-12-05
Reconsidering statins in MASLD: beyond cardiovascular protection to multisystem benefit
Phrase rank #2 · DOI 10.1136/gutjnl-2025-336430
Gut · 2025-10-15
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
Phrase rank #2 · DOI 10.1136/gutjnl-2025-336127
Gut · 2025-10-06
P12 A nurse-led, one-stop-shop approach to MASLD assessment, risk stratification and patient education: the belfast experience
Phrase rank #2 · DOI 10.1136/gutjnl-2025-BASL.29
Gut · 2025-10-06
P53 Acquired mutations in early stage metabolic-dysfunction associated steatotic liver disease (MASLD)
Phrase rank #2 · DOI 10.1136/gutjnl-2025-BASL.69
Gut · 2026-06-23
P325 Metabolic liver disease in early-onset colorectal cancer: a 15-year cohort from Oman reveals surprising patterns
Phrase rank #3 · DOI 10.1136/gutjnl-2026-BSG.437
Gut · 2026-06-23
P78 Low risk of advanced liver fibrosis in type 1 diabetes despite metabolic risk factors – results from universal fib4 screening
Phrase rank #3 · DOI 10.1136/gutjnl-2026-BSG.214
Gut · 2026-06-23
O11 External validation of ANTICIPATE-NASH model for non-Invasive CSPH detection in MASLD: a multicentre European study
Phrase rank #3 · DOI 10.1136/gutjnl-2026-BSG.11
Sexually Transmitted Infections · 2026-05-20
P104 Post-transplant comorbidities and MASLD development in liver recipients with and without HIV infection
Phrase rank #3 · DOI 10.1136/sextrans-ICAR-2026.141
Frontline Gastroenterology · 2026-04-07
Nutrition in MASLD: a patient focused, evidence-based clinician’s guide
Phrase rank #3 · DOI 10.1136/flgastro-2025-103183
BMJ Medicine · 2026-03-31
Metabolic dysfunction associated steatotic liver disease: mechanisms, diagnosis, and management in adults
Phrase rank #3 · DOI 10.1136/bmjmed-2025-002038
BMJ Open Gastroenterology · 2026-03-03
Using an integrative multi-omics and in vitro approach to investigate the role of tris(2-butoxyethyl) phosphate in promoting hepatic steatosis
Phrase rank #3 · DOI 10.1136/bmjgast-2025-002123
Gut · 2026-01-08
Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLD
Phrase rank #3 · DOI 10.1136/gutjnl-2025-336268
Gut · 2025-10-06
P16 MASLD & OSA in the bariatric population: prevalence, predictors & outcomes
Phrase rank #3 · DOI 10.1136/gutjnl-2025-BASL.33
Gut · 2026-06-26
IDDF2026-ABS-0362 Trajectory of liver-related events following incident cardiovascular disease in MASLD: a 15-year population-based cohort study
Phrase rank #4 · DOI 10.1136/gutjnl-2026-IDDF.205
Gut · 2026-06-26
IDDF2026-ABS-0232 Network pharmacology analysis of tagetes reveals multi-target mechanisms across the gut-liver axis in metabolic inflammation and MASLD
Phrase rank #4 · DOI 10.1136/gutjnl-2026-IDDF.107
BMJ Open Diabetes Research & Care · 2026-01-27
Serum soluble ASGR1 concentration is elevated in patients with metabolic dysfunction-associated steatotic liver disease and is associated with adiponectin
Phrase rank #4 · DOI 10.1136/bmjdrc-2025-005638
Gut · 2026-01-21
Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement
Phrase rank #4 · DOI 10.1136/gutjnl-2025-337374
Gut · 2025-10-06
P119 The association between metabolic dysfunction-associated steatotic liver disease and food insecurity in adults and children – a systematic review
Phrase rank #4 · DOI 10.1136/gutjnl-2025-BASL.132
Gut · 2025-09-08
Non-invasive tests of fibrosis in the management of MASLD: revolutionising diagnosis, progression and regression monitoring
Phrase rank #4 · DOI 10.1136/gutjnl-2025-335542